Tesla Model 3 Tesla's Stock Price

S&P 500, Technology and Biotech Showing Weakness

Subscribe to receive this FREE daily commentary directly in your email

S&P 500 Is Still Struggling

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”][/vc_column][/vc_row] Get This In Your E-Mail Subscribe

First I wanted to give a big Thank You to MarketWatch.com for doing a write-up on our blog post from over the weekend, regarding Tesla.

Tesla’s biggest news last week was not the truck, says this fund manager

[widget id=”wordads_sidebar_widget-18″]

The S&P 500 continues to deteriorate on a intraday basis, which again appears to be the making of a short-term pullback. I know we have been saying this for a days, but the chart tells the story. I am giving you my interpretation of what it represents.

S&P 500

[widget id=”wordads_sidebar_widget-18″]

Tesla

Tesla shares continue to hang in. Shares spiked to nearly $325, following the Truck and Roadster announcement. But the stock sold-off late Friday, and continued to sell-off today some.

Tesla

The chart shows how the share of Tesla managed to find some support on the uptrend, and continue to hold the above the $303 level. Continue to watch Tesla, as it continues to act as a risk gauge for the market.

[widget id=”wordads_sidebar_widget-18″]

[widget id=”wordads_sidebar_widget-18″]

Sign-up for our premium content on Seeking Alpha Market Place – “Reading The Markets”  and a get Two Week Free Trial Period

Premium Content Is Great For College Students, Non-Professional, and Professional Investors. It is designed to focus on what institutional investors are watching, based on Mike’s 20 plus years of professional analytic, trading, and portfolio management career.

Premium Content: Benefits include the ability to reach out to Mike with questions through a chat room, direct message, or comments. 

We will respond to questions in short order and will respond to questions with full-post or video segment, just not one or two-word answers. 

Just $40 per Month

Nailing The Biotech Breakout

Biotech’s Signal A Bottom

GE: Just Not Worth It Anymore

Disney Is Just Too Cheap

 Biotech

Biotech’s failed to rally today, and in fact, it was unable to get back over $309 after falling below. Concerning, yes. Does it mean the turn around is over? No.

https://www.tradingview.com/i/2hms0dSB/

[widget id=”wordads_sidebar_widget-18″]

In fact shares of Celgene briefly, touch support at $102.50 and managed to bounce right off.

CelG

Technology

Technology shares were also weak today, and again like the S&P 500 is showing signs of strain.

[widget id=”wordads_sidebar_widget-18″]

amazon

Unlock Deeper Insights with Exclusive Member-Only Video Content on The Market Chronicles YouTube Channel – Just $34.99/Month

Join this channel to get access to perks:https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/joinPlease check out my content on Substack and Seeking Alpha:https://www.themarketchronicle.com/https://seekingalpha.com/affiliate_link/Youtube81624#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment. 10:43
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuZElMZlVmSDJVT2M

Volatility In Focus

6 hours ago

Join this channel to get access to perks:https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/joinPlease check out my content on Substack and Seeking Alpha:https://www.themarketchronicle.com/https://seekingalpha.com/affiliate_link/Youtube81624#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment. 13:48
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEucGlQRjlVX3JsOFE

Strong JOLTS Report Sends Inflation Expectations Higher

December 3, 2024 1:24 PM

Join this channel to get access to perks:https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/joinPlease check out my content on Substack and Seeking Alpha:https://www.themarketchronicle.com/https://seekingalpha.com/affiliate_link/Youtube81624#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment. 11:04
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuZjdwbFZfYUp4Ums

Low Realized Vol Has Trapped The Stock Market

December 2, 2024 2:00 PM

Load More... Subscribe

[widget id=”wordads_sidebar_widget-18″]

Shares of Nvidia have also struggled to regain previous highs. I’m drawing a downtrend line as of today. We’ll see where it goes.

Nvidia

[widget id=”wordads_sidebar_widget-18″]

One last one is Amazon, sitting on the cusp. A break below its current $1,122 sends shares much much lower..

Amazon

Good night

[widget id=”wordads_sidebar_widget-18″]

Free Articles Written By Mike: 

Why The Worst Isn’t Over For IBM’s Stock

Amazon, Microsoft, and Apple May Fall Up To 11%

Qualcomm and NXP Are Cheap Based on Marvell Takeover

JP Morgan and Citigroup Are Facing More Decline

Why Biotech Sage Therapeutics Is Overvalued

Why NVIDIA’s Valuation May Be A Giant Bubble

Intel Could Fall 10 Percent Before Long-Term Rise

One Thing The Yield Curve Says About Stocks

Tesla’s Stock Heads To A Crossroad

Why Coca-Cola’s Biggest Return May Be Frustration

Biotech Alkermes Could Jump On Opioid Treatment Sales

Why GM Could Slide 10% After Bull Run

Why Biotech Stocks Are Nearing a Rebound

Higher Bid For Qualcomm Is Unlikely, Traders Indicate

Why Netflix, Nike and Starbucks Are Breaking Out

S&P 500 May Pull Back, Setting Up 20% Gain By End 2018

McDonald’s and Starbucks: A Case of Perception Vs. Reality

Nvidia Traders Expect More Gains for the Stock

Biotech Celgene Could Rebound By More Than 15%

Exxon, Chevron, and Oil Are Breaking Out

We offer a lot of great commentaries all week talking about the major and relevant market events. Be sure to subscribe to get all our free commentaries sent directly to your inbox or follow us on Twitter.

-OR-

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”][/vc_column][/vc_row]

Michael Kramer owns XLK Puts

Michael Kramer and the Clients of Mott Capital owns shares of CELG, TSLA

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.

© 2017 Mott Capital Management, LLC.  Use, publication or reproduction in any media prohibited without the permission of the copyright holder.

Tags: #Nvidia #SP500 #Technology #Microsoft #Amazon #Nvidia #IBB #Biotech

 

Add your email to The Market Chronicles' growing list of daily readers. A FREE market commentary on the trading day's most critical and least apparent events!

Add your email to The Market Chronicles' growing list of daily readers. A FREE market commentary on the trading day's most critical and least apparent events!